ScholarLens Back to search
1994•AIDSRequires access

OUTCOMES AND COSTS OF SHORT- AND LONGTERM RIFABUTIN PROPHYLAXIS FOR MYCOBACTERIUM AVIUM (MAC) DISEASE IN AIDS PATIENTS IN THE UNITED KINGDOM

K N Simpson, Roxanne Lavallée, D. Revicki

Open publisher page 1 citations

Abstract

Battelle Medical Technology and Policy Research Program (MEDTAP) and the University of North Carolina at Chapel Hill, USA

About this research paper

What this paper is about

Battelle Medical Technology and Policy Research Program (MEDTAP) and the University of North Carolina at Chapel Hill, USA

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Battelle Medical Technology and Policy Research Program (MEDTAP) and the University of North Carolina at Chapel Hill, USA

Key concepts: Rifabutin, Mycobacterium avium complex, Medicine, Mycobacterium avium-intracellulare infection, Disease, Opportunistic infection, AIDS-Related Opportunistic Infections, Intensive care medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
OUTCOMES AND COSTS OF SHORT- AND LONGTERM RIFABUTIN PROPHYLAXIS FOR MYCOBACTERIUM AVIUM (MAC) DISEASE IN AIDS PATIENTS IN THE UNITED KINGDOM — Research Paper | ScholarLens